Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine in Chronic Idiopathic Urticaria
NCT00199251Phase 3Terminated
- Sponsor
- Uriach
- Start
- Apr 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rupatadine in chronic idiopathic urticaria (CIU), sponsored by Uriach. Started Apr 2004; status: terminated.
02
Drugs
rupatadine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT00199251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199251.